Biopharmx (BPMX) News Today → War Over Taiwan? Protect Your Wealth NOW (From Behind the Markets) (Ad) Free BPMX Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTMBRQ Trex Wind-down, Inc.seekingalpha.com - April 20 at 12:48 AMTrex Wind Down Inc (TMBRQ)investing.com - April 18 at 12:14 AMBioPharmX (BPMX) Stock Soars on Potential 'Breakthrough' Acne Treatmentthestreet.com - July 8 at 5:32 PMForm 424B5 Timber Pharmaceuticals, - StreetInsider.comstreetinsider.com - October 3 at 12:35 PMOutlook on the Acne Treatment Global Market, to 2027 - Rising Public Knowledge of Cosmetic Acne Treatments is Driving Growth - Yahoo Financefinance.yahoo.com - September 22 at 11:16 AMGlobal Acne Treatment Market, By Therapeutic Class, By Formulation, By Type, By Acne Type, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027 - GlobeNewswireglobenewswire.com - July 19 at 12:59 PMTimber Pharmaceuticals, Inc. (TMBR) Stock Price Today, Quote & News - Seeking Alphaseekingalpha.com - July 17 at 1:20 PMForm DEF 14A Vivos Therapeutics, Inc. For: Jul 14 - StreetInsider.comstreetinsider.com - July 14 at 3:02 PMManagement's Discussion and Analysis of the Results of Operations - Marketscreener.commarketscreener.com - May 13 at 2:52 AMTimber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2021 Financial Results - GlobeNewswireglobenewswire.com - March 31 at 7:01 PMTIMBER PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.commarketscreener.com - March 31 at 5:36 PMAcne Drugs Global Market Report 2022 - Yahoo Financefinance.yahoo.com - March 16 at 10:33 AM2021 Metabolic Partnering Global Report - In-depth Understanding of Metabolic Deal Trends Since 2014 - Be - Benzingabenzinga.com - December 23 at 7:57 AMAramis Biosciences Launches to Address Unmet Needs in Ocular Immunology - GlobeNewswireglobenewswire.com - December 15 at 9:13 AMForm 10-Q Timber Pharmaceuticals, For: Sep 30 - StreetInsider.comstreetinsider.com - November 16 at 7:45 AMTimber Pharmaceuticals : Provides Business Update and Announces Third Quarter 2021 Financial Results - Form 8-K - marketscreener.commarketscreener.com - November 16 at 1:30 AMVenus Concept Appoints Ross J. Portaro as President of Global Sales - StreetInsider.comstreetinsider.com - October 13 at 8:35 AMForm 8-K Venus Concept Inc. For: Oct 05 - StreetInsider.comstreetinsider.com - October 13 at 12:44 AMVenus Concept Appoints Ross J. Portaro as President of Global Sales - GuruFocus.comgurufocus.com - October 12 at 9:42 AMAcne Vulgaris Pipeline: Therapeutic Assessment, Emerging Drugs, Key Pharma Players, Clinical Trials, and Growth Prospects Analysis - GlobeNewswireglobenewswire.com - October 11 at 9:03 PMForm PRER14A NEXTGEN HEALTHCARE, INC. - StreetInsider.comstreetinsider.com - August 31 at 4:33 PMForm PRE 14A NEXTGEN HEALTHCARE, INC. For: Oct 13 - StreetInsider.comstreetinsider.com - August 23 at 10:10 AMTimber Pharmaceuticals Provides Business Update and Announces Second Quarter 2021 Financial Results - GlobeNewswireglobenewswire.com - August 10 at 9:09 AMGelteq Appoints Seasoned Pharma and Tech Executive, James Pekarsky, as Chief Financial Officer - StreetInsider.comstreetinsider.com - July 22 at 1:07 PM Get Biopharmx News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMX and its competitors with MarketBeat's FREE daily newsletter. Email Address War Over Taiwan? Protect Your Wealth NOW (Ad)With tensions rapidly escalating, Taiwan could provide the spark at any moment. Don't let your financial future get caught in the crossfire unprepared. Access my report now >>> BPMX Media Mentions By Week BPMX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPMX News Sentiment▼0.000.33▲Average Medical News Sentiment BPMX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPMX Articles This Week▼10▲BPMX Articles Average Week Get Biopharmx News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KNTE News Today VTGN News Today NGM News Today NGENF News Today ASMB News Today SYRS News Today VTVT News Today BYSI News Today CYBN News Today PRQR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:BPMX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biopharmx Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.